NOT-AI-24-027: Notice of Early Expiration of "Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity", NOT-AI-21-082

Notice of Early Expiration of "Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity", NOT-AI-21-082

Notice Number:

NOT-AI-24-027

Key Dates

Release Date:

March 20, 2024

Related Announcements

March 20, 2024 - Notice of Special Interest (NOSI) Inborn Errors of Immunity/Primary Immunodeficiencies. See Notice NOT-AI-24-024.
March 20, 2024 - Notice of Early Expiration of "Notice of Special Interest (NOSI): Investigations on Inborn Errors of Immunity/Primary Immunodeficiencies", NOT-AI-21-032. See Notice NOT-AI-24-026.
November 29, 2021 - Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity. See NOT-AI-21-082

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community that NOT-AI-21-082, “Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity” will be expired as of March 20, 2024

Applicants are encouraged to consider applying to NOT-AI-24-024 – Notice of Special Interest (NOSI) Inborn Errors of Immunity/Primary Immunodeficiencies.

Inquiries

Please direct all inquiries to:

Maggie A. Morris Fears, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-761-5444
Email: [email protected]